Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Head and Neck Cancer Xenografts

Aesthetic Surgery Journal

Volumn 36, Issue 1, 2015, Pages 93-104

  Rowan, Brian G ^a   Lacayo, Eduardo A ^a   Sheng, Mei ^a   Anbalagan, Muralidharan ^a   Gimble, Jeffrey M ^a   Jones, Ryan K ^a   Joseph, Walter J ^b   Friedlander, Paul L ^a   Chiu, Ernest S ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; INTERLEUKIN 8; MATRIX METALLOPROTEINASE;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; CANCER GROWTH; CANCER MORPHOLOGY; CAPILLARY DENSITY; CELL COUNT; CELL MIGRATION; CHROMOSOME 17; COCULTURE; CONTROLLED STUDY; DNA DETERMINATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROMETASTASIS; MOUSE; MTT ASSAY; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR XENOGRAFT; ADIPOSE TISSUE; ANIMAL; BRAIN TUMOR; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; SECONDARY; SQUAMOUS CELL CARCINOMA; STEM CELL; STROMA CELL; XENOGRAFT;

ADIPOSE TISSUE; ANIMALS; BRAIN NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HEAD AND NECK NEOPLASMS; HETEROGRAFTS; HUMANS; MICE; MICE, NUDE; STEM CELLS; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84960454826     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1093/asj/sjv090     Document Type: Article

References (27)

1. Gutowski KA. Current applications and safety of autologous fat grafts: A report of the ASPS fat graft task force. Plast Reconstr Surg. 2009;124:272-280.
2. Kaufman MR, Bradley JP, Dickinson B, Heller JB,Wasson K, O'Hara C, Huang C, Gabbay J, Ghadjar K, Miller TA. Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short-and long-term results. Plast Reconstr Surg. 2007;119:323-331.
3. Mazzola RF, Cantarella G, Torretta S, Sbarbati A, Lazzari LPignataro L. Autologous fat injection to face and neck: from soft tissue augmentation to regenerative medicine. Acta Otorhinolaryngol Ital. 2011;31:59-69.
4. Torretta S, Pignataro L, Capaccio P, Brevi A, Mazzola R. Fat injections for the management of post-parotidectomy Frey syndrome: A technical note. J Craniomaxillofac Surg. 2012;40:173-176.
5. Dubois SG, Floyd EZ, Zvonic S, Kilroy G, Wu X, Carling S, Halvorsen YD, Ravussin E, Gimble JM. Isolation of human adipose-derived stem cells from biopsies and liposuction specimens. Methods Mol Biol. 2008;449:69-79.
6. Yu G, Floyd ZE, Wu X, Hebert T, Halvorsen YD, Buehrer BMGimble JM. Adipogenic differentiation of adiposederived stem cells. Methods Mol Biol. 2011;702:193-200.
7. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: Isolation, expansion and differentiation. Methods. 2008;45:115-120.
8. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc. 2009;4:495-505.
9. Rowan BG, Gimble JM, Sheng M, Anbalagan M, Jones RK, Frazier TP, Asher M, Lacayo EA, Friedlander PL, Kutner R, Chiu ES. Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts. PLoS One. 2014;9:e89595.
10. Anbalagan M, Carrier L, Glodowski S, Hangauer D, Shan BRowan BG. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor alpha positive breast cancer. Breast Cancer Res Treat. 2012;132(2):391-409.
11. Anbalagan M, Ali A, Jones RK, Marsden CG, Sheng M, Carrier L, Bu Y, Hangauer D, Rowan BG. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts. Mol Cancer Ther. 2012;11(9):1936-1947.
12. Li Z, Carrier L, Belame A, Thiyagarajah A, Salvo VA, Burow MERowan BG. Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast Cancer Res Treat. 2008;118(1):33-43.
13. Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R, Rowan BG. "A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies." BMC Cancer. 2012;12:10.
14. Marsden CG, Wright MJ, Carrier L, Moroz K, Rowan BG. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone. PLoS One. 2012;7:e47587.
15. Sasser AK, Sullivan NJ, Studebaker AW, Hendey LF, Axel AEHall BM. Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. FASEB J. 2007; 21:3763-3770.
16. Sasser AK, Mundy BL, Smith KM, Studebaker AW, Axel AE, Haidet AM, Fernandez SA, Hall BM. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett. 2007;254: 255-264.
17. Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB, Alt EU. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis. 2009;30:589-597.
18. Zimmerlin L, Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, Donnenberg VS. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A. 2011;17: 93-106.
19. Donnenberg VS, Zimmerlin L, Rubin JP, Donnenberg AD. Regenerative therapy after cancer: what are the risks? Tissue Eng Part B Rev. 2010;16:567-575.
20. Pinilla S, Alt E, Abdul Khalek FJ, Jotzu C, Muehlberg F, Beckmann C, Song YH. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. 2009;284:80-85.
21. Welte G, Alt E, Devarajan E, Krishnappa S, Jotzu C, Song YH. Interleukin-8 derived from local tissue-resident stromal cells promotes tumor cell invasion. Mol Carcinog. 2011;51(11):861-868.
22. Devarajan E, Song YH, Krishnappa S, Alt E. Epithelialmesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int J Cancer. 2012;131:1023-1031.
23. Xu Q, Wang L, Li H, Han Q, Li J, Qu X, Huang S, Zhao RC. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelialmesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-beta. Int J Oncol. 2012;41:959-968.
24. Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, Tims DT,Wang JX, Cheng L, Mohanan S, Buckley MR, Cohen I, Nikitin AY, Williams RM, Gourdon D, Reinhart-King CA, Fischbach C. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci USA. 2012;109:9786-9791.
25. Karnoub AE, Dash AB, Vo AP, Sullivan A, BrooksMW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449:557-564.
26. Frazier TP, Gimble JM, Devay JW, Tucker HA, Chiu ES, Rowan BG. Body mass index affects proliferation and osteogenic differentiation of human subcutaneous adipose tissue-derived stem cells. BMC Cell Biol. 2013;14:34.
27. Tseng MY, Liu SY, Chen HR, Wu YJ, Chiu CC, Chan PT, Chiang WF, Liu YC, Lu CY, Jou YS, Chen JY. Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma. Oral Oncol. 2009;45:771-776.